Skip to main content
SpringerLink
Log in

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background: One to 10% of women with metastatic breast cancer have a recurrence of their disease as an isolated lesion (local, regional, or distant) which may be treated by surgical resection, irradiation, or both. These are patients with stage IV breast cancer with no evidence of disease, or stage IV-NED. Because natural history and prognostic factors for patients with stage IV-NED are poorly determined, we decided to evaluate a group of patients with stage IV-NED treated at a single institution.

Patients and methods: Ninety-six patients with isolated recurrence of stage IV breast cancer were analyzed retrospectively. Treatment of loco-regional or distant recurrence was surgery in 18 patients and surgery plus irradiation in 78 patients. Seventy-nine patients received systemic therapy after loco-regional treatment (24 chemotherapy and 55 hormonotherapy). Prognostic factors were analyzed and correlated with disease-free survival (DFS) and overall survival (OS).

Results: Five-year DFS and OS for the whole group were 29% and 49% respectively. On the univariate analysis, patients without axillary nodal involvement at the time of mastectomy had significantly greater 5-year DFS and OS than patients with nodal involvement (51% vs. 14% and 70% vs. 34% respectively, p< 0.05). DFS was also significantly better for patients receiving systemic therapy after local treatment (31% vs. 19%). On the multivariate analysis, absence of nodal involvement and systemic therapy were associated with longer DFS (p = 0.044 and p = 0.008, respectively) and OS (p = 0.009 and p = 0.011, respectively). None of the other factors analyzed including menopausal status, T-stage, number of involved nodes, receptor status, adjuvant therapy, sites of first recurrence, or time from mastectomy to first recurrence had a predictive value for DFS and OS.

Conclusion: Patients with stage IV-NED have poor prognosis due to early development of metastatic disease. Absence of axillary nodal involvement at the time of mastectomy and systemic therapy following local management is associated with improved DFS and OS. These results suggest that systemic therapy after local treatment in stage IV-NED is indicated. Poor prognosis in patients with previous nodal involvement warrants new approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Buzdar AU, Blumenschein GR, Smith TL, Tashima CK, Hortobagyi GN, Yap Y, Gutterman JU, Hersh EM, Gehan EA: Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV-NED). J Surg Oncol 12: 27–40, 1979

    Google Scholar 

  2. Holmes FA, Buzdar AU, Kau S, Fraschini G, Ames FC, McNeese MD, Hortobagyi GN: Combined-modality approach for patients with isolated recurrences of breast cancer (IV-NED). The M.D. Anderson experience. Breast Dis 7: 7–20, 1994

    Google Scholar 

  3. Bedwinek JM, Lee J, Fineberg B, Ocwieza M: Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer 47: 2232–2235, 1981

    Google Scholar 

  4. Aberizk WJ, Silver B, Henderson IG, Cady B, Harris JR: The use of radiotherapy for treatment of isolated recurrence of breast carcinoma after mastectomy. Cancer 58: 1214–1218, 1986

    Google Scholar 

  5. Schwaibold F, Fowble BL, Solin LJ, Schultz DJ, Goodman RL: The results of radiation therapy for isolated localregional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 21: 299–310, 1991

    Google Scholar 

  6. Lo TCM, Salzman FA, Wright KA, Costey GE: Megavolt electron irradiation in the treatment of recurrent carcinoma of the breast on the chest wall. Acta Radiol 22: 97–99, 1983

    Google Scholar 

  7. Cormack PM, Bains MS, Burt ME, Martini N, Chaglassian T, Hidalgo DA: Local recurrent mammary carcinoma failing multimodality therapy. Arch Surg 124: 158–161, 1989

    Google Scholar 

  8. Chu FCH, Lin F, Kim JH, Huh SH, Garmatis CJ: Locally recurrent carcimoma of the breast. Results of radiation therapy. Cancer 37: 2677–2681, 1976

    Google Scholar 

  9. Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41: 1170–1178, 1978

    Google Scholar 

  10. Beck TM, Hart EN, Woodard DA, Smith CE: Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients. J Clin Oncol 1: 400–405, 1983

    Google Scholar 

  11. Andry G, Suciu S, Vico P, Faverly D, Andry-´tHooft M, Verhest A, Nogaret JM, Mattheiem W: Loco-regional recurrences after 649 modified radical mastectomies: incidence and significance. Eur J Surg Oncol 15: 476–485, 1989

    Google Scholar 

  12. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B: Loco-regional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy.AmJ Clin Oncol 15(2): 93–101, 1992

    Google Scholar 

  13. Janjan NA, McNeese MD, Buzdar AU, Montague DE, Oswald MJ: Management of loco-regional recurrent breast cancer. Cancer 58: 1552–1556, 1986

    Google Scholar 

  14. Gilliland MD, Barton RM, Copeland EM: The implications of local recurrence of breast cancer as the first site of therapeutic failure. Ann Surg 197: 284–287, 1983

    Google Scholar 

  15. Buzdar AU, Blumenschein GR, Montague DE, Hortobagyi GN: combined modality approach in breast cancer with isolated or multiple metastases. Am J Clin Oncol 6: 45–50, 1983

    Google Scholar 

  16. Di Prieto S, Bertario L, Piva L: Prognosis and treatment of loco-regional breast cancer recurrences: critical considerations on 120 cases. Tumori 66: 331–338, 1980

    Google Scholar 

  17. Mango L, Bignardi M, Micheletti E, Bardelli D, Plebani F: Analysis of prognosis factors in patients with isolated chest wall recurrence of breast cancer. Cancer 60: 240–244, 1987

    Google Scholar 

  18. Chen KK-Y, Montague DE, Oswald MJ: Results of irradiation in the treatment of loco-regional breast cancer recurrence. Cancer 56: 1269–1273, 1985

    Google Scholar 

  19. The Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339: 1–15, 71–84, 1992

    Google Scholar 

  20. Bedwinek JM, Ratkin GA, Philpott GW, Wallack M, Perez CA: Concurrent chemotherapy and radiotherapy for nonmetastatic, stage IV breast cancer. A pilot study by the Southeastern Cancer Study Group. Am J Clin Oncol 6: 159–165, 1983

    Google Scholar 

  21. Tookel LM, Fix Y, Jacobson LH, Wallach CB: The significance of local recurrence of carcinoma of the breast. Int J Radiat Oncol Biol Phys 9: 33–39, 1967

    Google Scholar 

  22. Borner M, Bacchi M, Goldhirsch A, Greiner R, Harder F, Castiglione M, Jungi WF, Th¨urlimann B, Cavalli F, Obrecht JP, Leyvraz S, Alberto P, Adam H, Varini M, Loehnert T, Senn HJ, Metzger U, Brunner K, for the Swiss Group for Clinical Cancer Research: First isolated loco-regional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. J Clin Oncol 12: 2071–2077, 1994

    Google Scholar 

  23. Pinnamaneni K, Buzdar AU, Blumenschein GR, Yap H, Gehan EA: Adriamycin-containing combination chemotherapy in patients with isolated recurrences of breast cancer in prior cyclophosphamide, methotrexate and fluorouracil treated patients following regional therapy–prolongation of second disease-free interval. Proc Am Soc Clin Oncol 112 (Abstr 436), 1983

  24. Weaver CH, West WH, Schwartzberg LS, Alberico T, Leff R, Greco FA, Hainsworth J, Birch R, McAneny B, Magee M, Raefsky E, Kalman L, Buckner CD: Induction, mobilization of peripheral blood stem cells (PBSC), highdose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intention to treat analysis. Bone Marrow Transplant 19: 661–670, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Medical Oncology, Hospital Clínico Universitario, University of Valencia, Valencia, Spain

    Oscar Juan, Ana Lluch, Laura de Paz, Felipe Prósper, Pilar Azagra, Isabel Marugán, Angel Martínez-agulló & Javier Garcia-conde

Authors
  1. Oscar Juan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Lluch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura de Paz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Felipe Prósper
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pilar Azagra
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Isabel Marugán
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Angel Martínez-agulló
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Javier Garcia-conde
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Juan, O., Lluch, A., de Paz, L. et al. Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED). Breast Cancer Res Treat 53, 105–112 (1999). https://doi.org/10.1023/A:1006090319083

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006090319083

Search

Navigation